Instil Bio, Inc. (TIL) stock
TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.24−0.07 (-1.11%)
Close on Nov 12, 2026Market cap $42.32MP/E –Yield –
Instil Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Instil Bio's enterprise value was $37.25M on Nov 11, 2026, against $80.74M a year earlier. Over the last 5 years it ranged from -$222.04M to $1.69B, with a median of $64.04M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $37.25M | -45.9% |
| 2025 | Dec 31, 2025 | $68.80M | -41.6% |
| 2024 | Dec 31, 2024 | $117.90M | – |
| 2023 | Dec 29, 2023 | -$134.90M | – |
| 2022 | Dec 30, 2022 | -$222.04M | -113.1% |
| 2021 | Dec 31, 2021 | $1.69B | – |
See a number that looks wrong?